US Cell Counting Market to Reach $1,223.3 Million by 2035 Driven by Expanding Cancer Screening Programs

US cell counting market was valued at $662.7 million in 2025 and is projected to reach $1,223.3 million by 2035, growing at a CAGR of 6.4% during the forecast period (2026–2035). The US cell counting market is witnessing growth opportunities driven by the expansion of cancer screening programs nationwide. Cell counting technologies are integral to clinical diagnostics and biomedical research, as they enable precise measurement of cell concentration, viability, and morphology across diverse sample types. These capabilities support early disease detection, treatment monitoring, and large-scale population screening initiatives. In 2025, an estimated 2,041,910 new cancer cases and 618,120 cancer-related deaths are projected in the US, underscoring the need for robust diagnostic infrastructure.

Browse the full report description of “US Cell Counting Market Size, Share & Trends Analysis Report by Product Type (Instruments and Consumables), By Application (Medical Applications, Research, and Industrial), By End-User (Pharmaceuticals & Biotechnology Companies, Research Institutes & CRO, and Hospitals & Diagnostic Laboratories), Forecast Period 2026-2035” at https://www.omrglobal.com/industry-reports/us-cell-counting-market

The rising burden of cancer has prompted broader adoption of organized screening programs across healthcare systems. The American Cancer Society’s 2024 Prevention and Screening Program illustrates this trend, encompassing 154 projects led by hospitals, public health agencies, and community health centres. These initiatives collectively reached more than 1.9 million screening-eligible individuals. Handling such high volumes of blood, tissue, and biopsy samples necessitates reliable and efficient laboratory workflows. As a result, demand is increasing for automated and high-throughput cell counting instruments that improve accuracy and operational efficiency. This growing reliance on advanced cell counting solutions is supporting sustained expansion of the US clinical cell counting market.

Key Developments and Strategic Expansions in the US Cell Counting and Diagnostics Market

The major companies operating in the US cell counting market include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

• In August 2025, Sonic Healthcare USA, Inc. announced the acquisition of Cairo Diagnostics LLC to expand its national hematology oncology testing capabilities. The transaction integrates Cairo’s comprehensive, medically led oncology diagnostics platform including molecular, cytogenetic, and flow cytometry services into Sonic’s nationwide network. The acquisition is expected to enhance access to high-complexity oncology testing and improve turnaround times for clinicians across the US.

• In July 2024, Danaher Corporation announced the launch of two new CLIA and CAP-certified Centers of Innovation in Diagnostics to accelerate the development of companion and complementary diagnostics. The centers will integrate technologies from multiple Danaher subsidiaries under one roof, streamlining biomarker validation, clinical assays, and commercialization. These initiatives aim to enhance precision medicine by enabling faster, more efficient development of targeted therapies for patients worldwide.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Application
  • By End-User
• Competitive Landscape - Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

US Cell Counting Market Report Segment

By Product Type

• Instruments
• Consumables

By Application

• Medical Applications
• Research

By End-User

• Pharmaceuticals and Biotechnology companies
• Research Institutes and CRO
• Hospitals and Diagnostic Laboratories

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-cell-counting-market